QDEL - QuidelOrtho Corporation
QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions.
As of May 15, 2026: spot at $10.45, ATM IV 96.0%, net GEX -$29.7K.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Market Cap
- $753.5M
- Beta
- 0.74
- 52-Week Range
- 9.92-35.58
- CEO
- Brian J. Blaser
- Employees
- 6,600
- IPO Date
- Feb 1, 1991
- Exchange
- NASDAQ
What QDEL Looks Like to Options Traders Today
IV rank of 28.3% is subdued relative to the 1-year history, conditions that typically favor premium-buying or long-volatility structures (debit spreads, calendar spreads, long straddles); negative net gamma exposure (-$29.7K) means dealers hedge with trend, amplifying realized volatility and accelerating directional moves; the 25-delta skew (0.088) prices calls richer than puts, often reflecting upside speculation or squeeze risk.
What This Page Covers
The QDEL overview links into per-metric analysis views: max pain, gamma exposure, volatility skew, expected move, options chain, open interest history, and aggregate Greeks. Microstructure data is available on short interest, short volume, fail-to-deliver, and market structure. Corporate data is on fundamentals, earnings, analyst ratings, and insider trading.
Frequently asked QDEL overview questions
- What is QDEL?
- QDEL is the ticker symbol for QuidelOrtho Corporation, a listed security. QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. Listed on NASDAQ. QDEL is the equity ticker shown on this page; equity options traders use the security for directional, volatility, and income strategies via the listed options chain.
- What does the QDEL options snapshot look like today?
- As of May 15, 2026, the QDEL options snapshot shows spot at $10.45, ATM IV 96.0%, IV rank 28.3%, net GEX -$29.7K, expected move 27.52%. The full options chain, Greeks by strike and expiration, per-strike open-interest distribution, dealer gamma and delta exposure, and the volatility skew surface are linked from this overview page. Each per-metric route refreshes once per trading session and reflects the most recent close-of-business listed-options state.
- What are QDEL's key statistics?
- QuidelOrtho Corporation (QDEL) carries a market capitalization of $753.5M, beta of 0.74 relative to the broader market, 52-week range of 9.92-35.58. Full income statement, balance sheet, cash flow, and TTM ratio history is on the per-ticker fundamentals page; daily price history and 52-week levels are accessible from the same view. These structural inputs frame how the options market prices implied volatility around earnings windows and capital events.
- What sector or industry does QDEL belong to?
- QuidelOrtho Corporation operates in the Healthcare sector, in the Medical - Instruments & Supplies industry. Sector classification affects how the ticker correlates with sector ETFs, how it reacts to macro factors like rate moves and commodity prices, and how its options pricing compares to sector peers. Compare QDEL's implied volatility and skew against sector benchmarks to gauge whether the options market is pricing single-name or systemic risk relative to the broader peer group.
- How current is the QDEL data on this page?
- The options snapshot above is dated May 15, 2026 and refreshes once per session, with all per-strike Greeks and exposure aggregates recomputed at the daily close. Company-profile fields (sector, industry, market cap, P/E, IPO date) refresh from the vendor feed nightly. Financials and earnings refresh as 10-K and 10-Q filings are parsed (typically within several business days of the actual report). FINRA microstructure data refreshes on the source's cadence (daily for short volume, bi-monthly for short interest, weekly for the OTC volume file, twice-monthly for SEC FTD).